Our brand values are aligned with our strategic direction and priorities. They describe what we do and what we stand for as a growing business within the Radiolabelling and Discovery sectors
Selcia has successfully completed 14C radiolabelled API projects on behalf of a diverse range of clients for phase 1 human trials, following MHRA GMP Certification in September 2010.
Selcia are proud to announce the publication of the latest posters on our proprietary CEfrag™ fragment screening technology and the Selcia Fragment Library.
It is with great sadness that we report the loss of two friends, Jim Little and Bruce Lowery.